초록접수 현황
| 20F-072 | 구연 발표 |
Surgical outcome of lung resection under extracoporeal membrane oxygenation support for patients with decreased cardiopulmonary function.
¹⁾Do Hyung Kim, MD, ²⁾Jong Myung Park, MD, ¹⁾Joohyung Son, MD, ¹⁾Sung Kwang Lee, MD
¹⁾ Department of Thoracic and Cardiovascular Surgery, Pusan National University Yangsan Hospital, Pusan National University College of Medicine, Yangsan, Gyeongsangnam-do, Republic of Korea.
²⁾Department of Thoracic and Cardiovascular Surgery, Busan Medical Center, Yeonje-Gu, Busan, South Korea
Purpose : As the application of ECMO expands in thoracic surgery, treatments under ECMO support are being attempted in various conditions such as lung resection for patients with lowered cardiopulmonary function. We studied lung resection under ECMO support for patients with decreased cardiopulmonary function.
Methods : Between January 2011 and December 2019, 19 patients were applied on ECMO during lung resection. They were classified into two groups according to the timing of ECMO insertion, group I was applied ECMO preoperative period for management of ARDS, and group II was perioperative ECMO insertion because one lung ventilation was impossible due to poor lung function on the contralateral side.
Results : ECMO Support types were 16 cases for VV ECMO and 3 cases for VA ECMO. The causative diseases were infectious lung disease in 8 case, lung malignancy in 7 case, and others in 4 case. Pneumonectomy in 5 cases, sleeve lobectomy in 2 cases, lobectomy in 10 cases, and others 2 cases were performed. There were no 30 days mortality. The hospital mortality was 4 cases. The causes of death were cancer recur, colon perforation, and pneumonia. 6 cases were Group I, and 13 cases was Group II. there was no difference between the two groups in terms of mortality, ICU stay, ECMO day and hospital stay, respectively.
Conclusion : ECMO provides a safe environment during thoracic surgery, and its complication rate is acceptable. Even in patients with poor lung function, such as ARDS, it can be safely performed under ECMO support.
Methods : Between January 2011 and December 2019, 19 patients were applied on ECMO during lung resection. They were classified into two groups according to the timing of ECMO insertion, group I was applied ECMO preoperative period for management of ARDS, and group II was perioperative ECMO insertion because one lung ventilation was impossible due to poor lung function on the contralateral side.
Results : ECMO Support types were 16 cases for VV ECMO and 3 cases for VA ECMO. The causative diseases were infectious lung disease in 8 case, lung malignancy in 7 case, and others in 4 case. Pneumonectomy in 5 cases, sleeve lobectomy in 2 cases, lobectomy in 10 cases, and others 2 cases were performed. There were no 30 days mortality. The hospital mortality was 4 cases. The causes of death were cancer recur, colon perforation, and pneumonia. 6 cases were Group I, and 13 cases was Group II. there was no difference between the two groups in terms of mortality, ICU stay, ECMO day and hospital stay, respectively.
Conclusion : ECMO provides a safe environment during thoracic surgery, and its complication rate is acceptable. Even in patients with poor lung function, such as ARDS, it can be safely performed under ECMO support.
첨부파일 : 표.docx
책임저자: Do-Hyung Kim
Department of Thoracic and Cardiovascular Surgery, Pusan National University Yangsan Hospital, Pusan National University College of Medicine, Yangsan, Gyeongsangnam-do, Republic of Korea.
발표자: Sung Kwang Lee, E-mail : drlsk@naver.com